MAKO Surgical Corp. Schedules 2008 Third Quarter Earnings Release and Conference...

MAKO Surgical Corp. Schedules 2008 Third Quarter Earnings Release and Conference
Call for Thursday, November 6, 2008

FT. LAUDERDALE, Fla., Oct. 23, 2008 (GLOBE NEWSWIRE) -- MAKO Surgical Corp.
(Nasdaq:MAKO) announced today that it plans to release third quarter 2008
financial results after market close on Thursday, November 6, 2008. Maurice R.
Ferre, M.D., President and Chief Executive Officer and Fritz L. LaPorte, Senior
Vice President and Chief Financial Officer of MAKO, will host a conference call
to review the third quarter results starting at 4:30 p.m. EST on the same day.
The call will be concurrently webcast.

To listen to the conference call please dial 800-811-8830 for domestic callers
and 913-312-0386 for international callers approximately ten minutes prior to
the start time. To access the live audio broadcast or the subsequent archived
recording, visit the Investor Relations section of MAKO's website at
www.makosurgical.com. Following the call, a webcast replay will be available on
MAKO's website, and an audio replay will also be available by calling
888-203-1112 (719-457-0820 for international callers) and entering the passcode
3344855. Both the audio and webcast replays will be available through November
20, 2008.

About MAKO Surgical Corp.

MAKO Surgical Corp. is a medical device company that markets its advanced
robotic-arm solution and implants for minimally invasive orthopedic knee
procedures. The MAKO Tactile Guidance System(tm) (TGS(tm)) is a
surgeon-interactive tactile platform that incorporates a robotic arm and
patient-specific visualization technology and prepares the knee joint for the
precise and consistently reproducible insertion and alignment of resurfacing
implants through a minimal incision. This FDA-cleared TGS allows surgeons to
provide a tissue-sparing, bone resurfacing procedure called MAKOplasty(r) to a
large, yet underserved patient-specific population suffering from early to
mid-stage osteoarthritic knee disease. MAKO has an intellectual property
portfolio of more than 200 licensed or owned patents and patent applications
relating to the areas of computer assisted surgery, haptics, robotics and
implants. Additional information can be found at www.makosurgical.com.

-0-
CONTACT: MAKO Surgical Corp.
Investors:
Susan M. Verde
954-927-2044 x349
sverde@makosurgical.com

Westwicke Partners
Mark Klausner
410-321-9650
mark.klausner@westwickepartners.com